Search filters

List of works by David Gershenson

4-HPR modulates gene expression in ovarian cells

scientific article published on September 2006

A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma

scientific article published on 02 August 2010

A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer

scientific article published on August 2004

A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)

A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer

scientific article

A phase II trial of oral capecitabine in patients with platinum--and taxane--refractory ovarian, fallopian tube, or peritoneal cancer.

scientific article published on 3 March 2006

A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary

scientific article published on 09 February 2007

Accuracy of Intraoperative Frozen Section Diagnosis of Borderline Ovarian Tumors by Hospital Type

scientific article published on 19 April 2018

Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience.

scientific article published on 27 January 2017

Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors.

scientific article

Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors

scientific article

Adult granulosa cell tumors of the ovary in two first-degree relatives

scientific article published on September 2005

An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients

scientific article published in November 2004

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience

scientific article published on 11 August 2017

An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.

scientific article

Analysis of EphA2 expression and mutant p53 in ovarian carcinoma

scientific article published on 31 October 2006

Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors

scientific article

Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma

scientific article published on 13 August 2009

Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma

scientific article

Antitumor and antivascular effects of AVE8062 in ovarian carcinoma

scientific article

Association between adiponectin, insulin resistance, and endometrial cancer

scientific article published on 01 June 2006

Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3

scientific article

Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast

scientific article published on 01 May 2002

BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas

scientific article

Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion

scientific article

Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome

scientific article published on 01 February 2004

CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer.

scientific article published on June 2013

Calcifications in ovary and endometrium and their neoplasms

scientific article published in March 2003

Case-control comparison of quality of life in long-term ovarian germ cell tumor survivors: a gynecologic oncology group study

scientific article published on January 2008

Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series.

scientific article

Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study.

scientific article published on 27 July 2009

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

scientific article published on 23 July 2006

Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma

scientific article published on 26 October 2006

Classification of ovarian cancer: a genomic analysis.

scientific article published on January 2008

Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer

scientific article

Clinical and biological significance of vascular endothelial growth factor in endometrial cancer

scientific article published on December 2007

Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary

scientific article published on August 2006

Clinical management potential tumours of low malignancy

scientific article

Clinical trial methodology in rare gynecologic tumor research: Strategies for success.

scientific article published on 23 April 2018

Clinicodemographic factors influencing outcomes in patients with low-grade serous ovarian carcinoma

scientific article

Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma

scientific article published on 22 February 2007

Complete Resection Is Essential in the Surgical Treatment of Gestational Trophoblastic Neoplasia

scientific article published on 01 October 2018

Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival

scientific article published in November 2022

Conundrums in the management of malignant ovarian germ cell tumors: Toward lessening acute morbidity and late effects of treatment.

scientific article

Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

scientific article published on 01 May 2019

Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference

article

Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway

scientific article published on 01 June 2007

Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary

scientific article published on March 14, 2012

DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry

scientific article published on 13 October 2017

Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy

scientific article published in April 2004

Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study

scientific article published on 15 January 2020

Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations

scientific article published on 26 November 2020

ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.

scientific article published on 09 February 2017

Effects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma

scientific article published on 01 December 2019

Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer

scientific article published on November 2006

Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: results of a phase 2 trial of the Gynecologic Oncology Group

scientific article

Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum

scientific article published on 5 May 2008

Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors

scientific article published on 02 October 2020

Endometrial cancer in young, normal-weight women

scientific article published on 26 July 2005

Epithelial Ovarian Cancer

scientific article published on 01 January 2011

Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations Missed Opportunities

scholarly article by Larissa A. Meyer et al published July 2010 in Obstetrical and Gynecological Survey

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities

scientific article published on May 2010

Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results

scientific article published on May 1, 2003

Evolving population-based statistics for rare epithelial ovarian cancers

scientific article published on 15 January 2020

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium

scientific article published in August 2003

Expression of imatinib mesylate-targeted kinases in endometrial carcinoma

scientific article published in October 2004

Expression of metastasis-related genes in human epithelial ovarian tumors

scientific article published on January 2002

Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines

scientific article published on April 2004

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

scientific article

Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer

scientific article

FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper.

scientific article

Fallopian tube cancer: stepchild or mother?

scientific article published on 01 December 2007

Fertility preservation in rare ovarian tumors

scientific article published in March 2021

Fertility-sparing surgery for malignancies in women

scientific article

Fertility-sparing therapy for young women with endometrial cancer

scientific article

Fifth International Conference on Ovarian Cancer: challenges and opportunities.

scientific article published in June 2005

Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.

scientific article

Functional role of matrix metalloproteinases in ovarian tumor cell plasticity

scientific article published on April 2004

Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma

scientific article

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy

article

Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome

scientific article

Grading ovarian serous carcinoma using a two-tier system

scientific article published on 01 April 2004

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.

scientific article

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors).

scientific article

Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome

scientific article published in March 2005

HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma

scientific article

Healthcare reform: it's time

scientific article published on 25 August 2009

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma

scientific article published on 01 August 2004

Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum

scientific article published on 21 February 2017

Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum

scientific article published on March 6, 2012

Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas

scientific article published in June 2005

Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor.

scientific article

Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.

scientific article

Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum.

scientific article published on 20 October 2015

Impact of vessel maturation on antiangiogenic therapy in ovarian cancer

scientific article published on April 2008

Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.

scientific article published on 28 January 2011

In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.

scientific article

In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer

scientific article

Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer.

scientific article published on 11 March 2016

Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.

scientific article

Induction of tumor-reactive CTL by C-side chain variants of the CTL epitope HER-2/neu protooncogene (369-377) selected by molecular modeling of the peptide: HLA-A2 complex

scientific article published on October 2002

Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors

scientific article published on 17 December 2022

Integrating the Gynecologic Oncology Group and Gynecologic Cancer SPOREs--a square peg in a round hole or fits like a glove?

scientific article published on 16 February 2007

Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer

scientific article published on 30 December 2006

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas

scientific article

Irinotecan in epithelial ovarian cancer.

scientific article

Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative

scientific article

Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?

scientific article published on 05 June 2018

Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?

scientific article published on 03 December 2010

Is micropapillary serous carcinoma for real?

scientific article published on 01 August 2002

KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary.

scientific article

KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma

scientific article published in December 2013

Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary

scientific article published on 9 February 2007

Letter from Houston "So what part of 'stable disease' do you not understand?"

scientific article published on 19 January 2009

Limited public knowledge of obesity and endometrial cancer risk: what women know

scientific article published on 01 October 2008

Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells

scientific article published on 29 July 2016

Low grade serous ovarian carcinoma: identifying variations in practice patterns

scientific article published on 01 January 2019

Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.

scientific article published in December 2005

Low-grade serous carcinoma: new concepts and emerging therapies.

scientific article published on 23 May 2013

Low-grade serous ovarian cancer: State of the science

scientific article published on 20 January 2020

Low-grade serous ovarian cancer: a unique disease

scientific article

Low-grade serous ovarian cancer: expert consensus report on the state of the science

scientific article published on 17 August 2023

Low-grade serous primary peritoneal carcinoma

scientific article published on 11 March 2011

Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer.

scientific article published on 11 September 2006

MEK Inhibitors for the Treatment of Low-Grade Serous Ovarian Cancer: Expanding Therapeutic Options for a Rare Ovarian Cancer Subtype

scientific article published on 08 September 2020

Management of Rare Ovarian Cancer Histologies

scientific article published on 12 August 2019

Management of borderline ovarian tumours

scientific article

Management of ovarian germ cell tumors

scientific article published on July 2007

Management of rare epithelial ovarian cancers

Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report

scientific article published in January 2004

Mentoring in gynecologic oncology fellowship training and beyond

scientific article published on April 1, 2012

Mentorship and productivity among gynecologic oncology fellows

scientific article published in January 2003

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

scientific article published on January 2007

Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases

scientific article published on 01 September 2002

Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer

scientific article published on 01 January 2004

Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis

scientific article

Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review

scientific article published on 29 May 2020

Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma.

scientific article published in February 2003

Mucinous Ovarian Carcinoma

scientific article published on 01 July 2019

Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes

scientific article published on 20 February 2019

NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019

scientific article published on 01 August 2019

Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum

scientific article

Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.

scientific article published on 25 July 2009

Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity

scientific article published on 19 September 2007

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas

scientific article

On-Site Fertility Preservation Services for Adolescents and Young Adults in a Comprehensive Cancer Center

scientific article published on 15 November 2016

Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

scientific article published in September 2016

Ovarian Cancer, Version 3.2012

scientific article published on November 1, 2012

Ovarian Mucinous Neoplasms, Intestinal Type, in Premenopausal Patients, Develop in Abnormal Ovaries

scientific article published on 20 November 2020

Ovarian Sex Cord-Stromal Tumors

scientific article published on October 2016

Ovarian Yolk Sac Tumors; Does Age Matter?

scientific article published on 30 November 2017

Ovarian and extraovarian endometriosis-associated cancer

scientific article published on 01 October 2002

Ovarian cancer clinical practice guidelines.

scientific article

Ovarian cancer, version 2.2013.

scientific article

Ovarian cancer. Clinical practice guidelines in oncology

scientific article published in October 2006

Ovarian cancer. Clinical practice guidelines in oncology

scientific article published on 01 September 2008

Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?

scientific article published in March 2010

Ovarian low-grade serous carcinoma: a comprehensive update

scientific article published on 30 April 2012

Overexpression of kallikrein 10 in epithelial ovarian carcinomas

scientific article

Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients.

scientific article published on July 2007

PAX2 Expression in Ovarian Cancer

scientific article published on 15 March 2013

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas

scientific article published on 12 June 2009

Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?

scientific article

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

scientific article

Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted?

scientific article published on 21 January 2009

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration

scientific article

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

scientific article published in March 2004

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer

scientific article published on 06 April 2012

Peritoneal lesions in guinea pigs treated with hormones

scientific article published in October 2002

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

scientific article

Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer

scientific article published on 05 October 2020

Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer

scientific article published in October 2007

Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma

scientific article

Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)

scientific article published on 05 May 2018

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.

scientific article published on 3 November 2005

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube

scientific article published on 28 February 2012

Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.

scientific article published in January 2003

Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer

scientific article published on 09 October 2020

Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker

scientific article

Poor survival with wild-type TP53 ovarian cancer?

scientific article

Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study

scientific article

Preoperative Factors Predicting Survival After Secondary Cytoreduction for Recurrent Ovarian Cancer

scientific article published on 01 July 2011

Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma

scientific article

Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary

scientific article

Prevention of ovarian cancer: intraepithelial neoplasia.

scientific article

Proceedings from the 9th International Conference on Ovarian Cancer

scientific article published on December 28, 2011

Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome

scientific article published on 01 January 2006

Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.

scientific article published in September 2006

Prospective Determination of Prevalence of Lynch Syndrome in Young Women With Endometrial Cancer

scientific article published on 09 October 2007

Prospective evaluation of insulin resistance among endometrial cancer patients

scientific article

Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome

scientific article published on 02 May 2013

Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residu

scientific article

Quality of life and sexual functioning in cervical cancer survivors

scientific article published in October 2005

Quality of life in long-term survivors of ovarian germ cell tumors: a Gynecologic Oncology Group study

scientific article

Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.

scientific article published on September 2006

RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.

scientific article published on 12 February 2013

Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum‐resistant ovarian cancer

scientific article published on 27 November 2023

Rare Gynecologic Tumors: Coming of Age

scientific article published on 01 April 2020

Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study

scientific article

Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant

scientific article published on 10 April 2009

Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model

scientific article published in March 2007

Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study

article by David M Gershenson et al published 1 July 2007 in Journal of Clinical Oncology

Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential

scientific article published on 01 January 2002

Response to re-challenge of a MEK inhibitor in a patient with recurrent low-grade serous carcinoma of the peritoneum

scientific article published on 02 November 2020

Risk factors for young premenopausal women with endometrial cancer

scientific article

Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors

scientific article published on 25 January 2017

Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer.

scientific article published on May 2011

SEER data: perspective at 10,000 feet

scientific article published on 01 August 2008

STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot study.

scientific article

Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?

scientific article published on 2 May 2017

Sarcomatoid carcinoma of the cervix.

scientific article

Selected highlights from the 5th International Conference on Ovarian Cancer. Houston, TX, USA, 1-4 December 2004.

scientific article

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

scientific article published on May 2004

Selective activation of ceruloplasmin promoter in ovarian tumors: potential use for gene therapy

scientific article published on March 2004

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

scientific article published on 21 December 2012

Serous carcinoma of the ovary, fallopian tube, or peritoneum presenting as lymphadenopathy

scientific article published on 01 September 2004

Significance of lymph node ratio on survival of women with borderline ovarian tumors

scientific article published on 17 April 2020

Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis

scientific article published in October 2007

Specific keynote: molecular therapeutics in ovarian cancer

scientific article

Stage IIIC ovarian/peritoneal serous carcinoma: a heterogeneous group of patients with different prognoses.

scientific article

Stress hormone-mediated invasion of ovarian cancer cells

scientific article

Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.

scientific article

Successful pregnancy following chemotherapy in a survivor of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): A case report and review of literature

scientific article published on 28 April 2020

Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancer.

scientific article

Survival in women with grade 1 serous ovarian carcinoma

scientific article

Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases

scientific article published in August 2004

Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer

scientific article

The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary

scientific article published on 28 September 2006

The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy

scientific article published on 19 October 2020

The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors

scientific article

The activity of taxanes in the treatment of sex cord-stromal ovarian tumors

scientific article

The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer

scientific article

The association of benign and malignant ovarian adenofibromas with breast cancer and thyroid disorders

scientific article

The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer

scientific article

The continuum of serous tumors of low malignant potential and low-grade serous carcinomas of the ovary

scientific article published on January 2007

The future of gynecologic oncology: Are we headed for super-specialization?

scientific article published on May 4, 2011

The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes

scientific article published in June 2022

The heterogeneity of epithelial ovarian cancer: getting it right

scientific article published on 01 March 2010

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

scientific article

The life and times of low-grade serous carcinoma of the ovary

scientific article published on January 2013

The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.

scientific article

The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent

scientific article published on 01 November 2006

The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance

scientific article published on 22 July 2020

The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer

scientific article published on 8 November 2014

The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas

scientific article published on 01 November 2004

Time for action: a "sea change" in treatment strategies for rare types of epithelial ovarian cancer

scientific article published on 01 July 2007

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial

scientific article published in February 2022

Treatment of Ovarian Cancer in Young Women

scientific article published on March 1, 2012

Treatment of Rare Epithelial Ovarian Tumors

scientific article published on 01 December 2018

Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro

scientific article published in September 2002

Trends among gynecologic oncology inpatient deaths: is end-of-life care improving?

scientific article

Trends of low-grade serous ovarian carcinoma in the United States

scientific article published in January 2018

Unmasking the complexities of mucinous ovarian carcinoma

scientific article

Update on the management of ovarian germ cell tumors.

scientific article

Updates and emerging therapies for rare epithelial ovarian cancers: one size no longer fits all.

scientific article

Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer

scientific article

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

scientific article published on December 2003

Utility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary

scientific article published on 15 February 2014

Women With Synchronous Primary Cancers of the Endometrium and Ovary: Do They Have Lynch Syndrome?

scientific article published on 01 December 2005

[IV. Current Status and Future Perspectives in Low-Grade Serous Cancer of the Ovary]

beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma

scientific article published on 01 March 2003